Director, Clinical Research — RNAi Therapeutics Lead (Phase 2–3)
Alnylampharmaceuticals
- Cambridge
- Full-Time
- Health Sciences & Administration
- 81000 - 99000 £ / year (est.)
Posted 1 hour ago
10000+ jobs
Alnylampharmaceuticals
Cycle Pharmaceuticals
IQVIA
Amgen Foundation, Inc.
Editas Medicine
OGT
AstraZeneca Plc
AiLux S.r.l.
Editas Medicine
Jazz Pharmaceuticals